Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Cdkl5 in Different Atypical Rett Syndrome Variants: Description of the First Eight Patients from Spain

Clinical features and gene mutational spectrum of CDKL5 -related diseases in a cohort of Chinese patients

MECP2 and CDKL5 Gene Mutation Analysis in Chinese Patients with Rett Syndrome

Novel CDKL5 Mutations Were Found in Patients in China: Retrospective Investigation in Cases of CDKL5-related Disorders

Rett and Rett-like syndrome: Expanding the genetic spectrum to KIF1A and GRIN1 gene.

Report of 7 CDKL5 disorder cases

Molecular characteristics of Chinese patients with Rett syndrome.

Cdkl5, A Protein Associated With Rett Syndrome, Regulates Neuronal Morphogenesis Via Rac1 Signaling

Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome

Methyl-CpG-binding protein 2 gene and CDKL5 gene mutation in patients with Rett syndrome: analysis of 177 Chinese pediatric patients

Deletions in the CDKL5 5′ untranslated region lead to CDKL5 deficiency disorder

Delineation of Structural Rearrangements as an Overlooked Recurrent Pathological Mechanism

Characterization of the Relationship of CDKL5 with MeCP2 and Dnmt1 in PrimaryRat Cortical Neurons

Novel FOXG1 Mutations in Chinese Patients with Rett Syndrome or Rett-like Mental Retardation.

Longitudinal, multidimensional, observational study of 15 patients with CDKL5 Deficiency Disorder

Genomic analysis in Chilean patients with suspected Rett syndrome: keep a broad differential diagnosis

MECP2 Gene Mutation Analysis in Chinese Patients with Rett Syndrome

[Genetic Features and Mechanism of Rett Syndrome in Chinese Population].

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

Rett Syndrome In China - Report Of 9 Patients

Novel MEF2C Point Mutations in Chinese Patients with Rett (−like) Syndrome or Non-Syndromic Intellectual Disability: Insights into Genotype-Phenotype Correlation